Name | MUNITSIPAL'NOE UNITARNOE PREDPRIYATIE "APTEKA N 62" |
|---|
INN | 1420000118 |
|---|
KPP | 142001001 |
|---|
OGRN | 1021400791609 |
|---|
OKPO | 36971375 |
|---|
Address | 678730, Respublika Sakha (yakutiya), u. Oymyakonskiy, pgt Ust'-nera, ul. Lenina, d. D. 8 |
|---|
Phone | 2-28-51 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) |
Registration date | 20.09.2002 |
|---|
Registering department | Administratsiya Oymyakonskogo ulusa Respubliki Sakha (Yakutiya) |
|---|
|
MUP "APTEKA N62" (Sakha (Yakutia) Republic; INN 1420000118) was registered on 20 Sep 2002. The company's authorized capital as of July 1, 2012 was 101000 rub. Type of ownership of MUP "APTEKA N62" - Unitary enterprises based on the principle of economic management. Form of ownership of MUP "APTEKA N62" - Municipal property. Principal activities of MUP "APTEKA N62": retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2023
Net profit (RAS) of MUP APTEKA N62 grew over 2023 by 21.41% to 499.00 thousand RUB from 411.00 thousand RUB over 2022, the company informed. Revenue increased in the accounting period by 0.71% to 22.19 million RUB from 22.04 million RUB over 2022; cost of goods sold decreased by 11.99% to 14.03 million RUB from 15.94 million RUB; sales profit went up 1.65 times to 1.15 million RUB from 694.00 thousand RUB. 2022
Net profit (RAS) of MUP APTEKA N62 grew over 2022 by 35.64% to 411.00 thousand RUB from 303.00 thousand RUB over 2021, the company informed. Revenue increased in the accounting period by 24.60% to 22.04 million RUB from 17.69 million RUB over 2021; cost of goods sold grew by 26.86% to 15.94 million RUB from 12.56 million RUB; sales profit went up by 35.28% to 694.00 thousand RUB from 513.00 thousand RUB. 2021
Net profit (RAS) of MUP APTEKA N62 grew over 2021 4.73 times to 303.00 thousand RUB from 64.00 thousand RUB over 2020, the company informed. Revenue increased in the accounting period by 46.92% to 17.69 million RUB from 12.04 million RUB over 2020; cost of goods sold grew 1.88 times to 12.56 million RUB from 6.67 million RUB; sales profit went up 2.04 times to 513.00 thousand RUB from 252.00 thousand RUB. 2020
Net profit (RAS) of MUP APTEKA N62 grew over 2020 8.00 times to 64.00 thousand RUB from 8.00 thousand RUB over 2019, the company informed. Revenue decreased in the accounting period by 26.14% to 12.04 million RUB from 16.30 million RUB in 2019; cost of goods sold decreased by 9.27% to 6.67 million RUB from 7.36 million RUB; sales profit went up by 14.55% to 252.00 thousand RUB from 220.00 thousand RUB. 2019
Net profit (RAS) of MUP APTEKA N62 dropped in 2019 2.50 times to 8.00 thousand RUB from 20.00 thousand RUB over the same period in 2018, the company informed. Revenue decreased in the accounting period by 13.26% to 16.30 million RUB from 18.79 million RUB in 2018; cost of goods sold decreased by 31.80% to 7.36 million RUB from 10.79 million RUB; sales profit fell by 23.34% to 220.00 thousand RUB from 287.00 thousand RUB. 2018
Net profit (RAS) of MUP APTEKA N62 dropped in 2018 3.20 times to 20.00 thousand RUB from 64.00 thousand RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 36.80% to 18.79 million RUB from 29.73 million RUB in 2017; cost of goods sold decreased by 46.28% to 10.79 million RUB from 20.08 million RUB; sales profit fell by 28.61% to 287.00 thousand RUB from 402.00 thousand RUB. 2017
Net profit (RAS) of MUP APTEKA N62 dropped in 2017 by 23.81% to 64.00 thousand RUB from 84.00 thousand RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 14.32% to 29.73 million RUB from 34.70 million RUB in 2016; cost of goods sold decreased by 16.12% to 20.08 million RUB from 23.94 million RUB; sales profit fell by 16.42% to 402.00 thousand RUB from 481.00 thousand RUB. 2016
Net profit (RAS) of MUP APTEKA N62 dropped in 2016 2.27 times to 84.00 thousand RUB from 191.00 thousand RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 1.64% to 34.70 million RUB from 34.14 million RUB over 2015; cost of goods sold decreased by 0.66% to 23.94 million RUB from 24.10 million RUB; sales profit fell by 22.42% to 481.00 thousand RUB from 620.00 thousand RUB. 2014
Net profit (RAS) of MUP APTEKA N62 grew over 2014 by 31.33% to 109.00 thousand RUB from 83.00 thousand RUB over 2013, the company informed. Revenue increased in the accounting period by 6.52% to 28.66 million RUB from 26.91 million RUB over 2013; cost of goods sold grew by 7.05% to 19.26 million RUB from 17.99 million RUB; sales profit went up by 41.41% to 420.00 thousand RUB from 297.00 thousand RUB. 2013
Net profit (RAS) of MUP APTEKA N62 grew over 2013 by 29.69% to 83.00 thousand RUB from 64.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period by 27.27% to 26.91 million RUB from 21.14 million RUB over 2012; cost of goods sold grew by 42.09% to 17.99 million RUB from 12.66 million RUB; sales profit fell by 17.04% to 297.00 thousand RUB from 358.00 thousand RUB. 2012
Net profit (RAS) of MUP APTEKA N62 grew over 2012 by 3.23% to 64.00 thousand RUB from 62.00 thousand RUB over 2011, the company informed. Cost of goods sold grew by 3.02% to 12.66 million RUB from 12.29 million RUB; sales profit went up 1.61 times to 358.00 thousand RUB from 222.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|